Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “pMN”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00272493
What this trial is testing

Safety and Effectiveness of an Adjuvant in Improving Immune Response to Hepatitis B Virus Vaccine in HIV Infected Individuals

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 48
Not applicableUnknownNCT04100655
What this trial is testing

The Effect of the GM-CSF Gel on the Endometrial Thickness in Infertile Women With Thin Endometrium

Who this might be right for
Thin Endometrium
Sir Run Run Shaw Hospital 96
Early research (Phase 1)Study completedNCT02762799
What this trial is testing

Clinical Trial to Evaluate Pharmacokinetics, Pharmacodynamics and Safety of Leucostim® Compared to Neupogen®

Who this might be right for
Leucocytosis
Biocad 60
Early research (Phase 1)UnknownNCT05222009
What this trial is testing

G-CSF in Patients With Anti-PD-1-axis Therapy-resistant Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Granulocyte Colony-Stimulating FactorPD-1 Inhibitor
Sun Yat-sen University 25
Testing effectiveness (Phase 2)Study completedNCT00011934
What this trial is testing

Bone Marrow Transplantation Plus Biological Therapy in Treating Patients With Chronic Myeloid Leukemia

Who this might be right for
Leukemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Study completedNCT00025805
What this trial is testing

G-CSF to Treat Crohn's Disease

Who this might be right for
Crohn's Disease
National Institute of Allergy and Infectious Diseases (NIAID) 23
Not applicableStudy completedNCT06608303
What this trial is testing

Macrophage Stimulating Factor in the Treatment of Diabetic Wounds

Who this might be right for
Diabetic Wound
Peking University Third Hospital 40
Not applicableStudy completedNCT02305979
What this trial is testing

Evaluation of Loratadine for G-CSF Induced Bone Pain in Patients With Hematologic Malignancies

Who this might be right for
LeukemiaLymphoma
Wake Forest University Health Sciences 61
Testing effectiveness (Phase 2)Ended earlyNCT03883386
What this trial is testing

Loratadine for Improvement of Bone Pain in Patients With Chronic Granulocyte-Colony Stimulating Factor (G-CSF) Use

Who this might be right for
Bone Pain
University of Michigan 3
Not applicableStudy completedNCT03189888
What this trial is testing

Granulocyte-monocyte Apheresis in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Valduce Hospital 33
Large-scale testing (Phase 3)Study completedNCT04466137
What this trial is testing

Phase 3 Study to Evaluate the Safety and Efficacy of YPEG-rhG-CSF in Malignancies Receiving Chemotherapy

Who this might be right for
Non-Myeloid Malignancy
Xiamen Amoytop Biotech Co., Ltd. 398
Large-scale testing (Phase 3)Study completedNCT01735175
What this trial is testing

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®

Who this might be right for
Neutropenic ComplicationsBreast NeoplasmsChemotherapy-induced Neutropenia+1 more
Sandoz 316
Early research (Phase 1)UnknownNCT02814110
What this trial is testing

Efficacy Safety of Granulocyte Colony-stimulating Factor Treatment Children and Adolescents With Muscular Dystrophy

Who this might be right for
Increase Muscle Strength in Patients With Muscular Dystrophy
Medical University of Bialystok 27
Large-scale testing (Phase 3)Ended earlyNCT02442180
What this trial is testing

Efficacy and Safety of G-CSF in Patients With Severe Alcoholic Hepatitis With Null or Partial Response to Steroid

Who this might be right for
Alcoholic Hepatitis
Chuncheon Sacred Heart Hospital 64
Early research (Phase 1)WithdrawnNCT05717140
What this trial is testing

Aerosolized Sargramostim Added to Immunotherapy for the Treatment of Patients With Metastatic Melanoma to the Lung

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Malignant Neoplasm in the LungMetastatic Melanoma+2 more
Mayo Clinic
Large-scale testing (Phase 3)UnknownNCT03163862
What this trial is testing

G-CSF Administration in IVF in a Preferable Preceptive Endometrium Score

Who this might be right for
Women Infertility
Istishari Arab Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00252915
What this trial is testing

Reconstruction of Monocytic Immunocompetence by Granulocyte-macrophage-colony Stimulating Factor (GM-CSF) in Patients With Severe Sepsis and Septic Shock

Who this might be right for
Sepsis
Charite University, Berlin, Germany 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT01757626
What this trial is testing

Combination Therapy of Antibody Hu3F8 With Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Relapsed/Refractory High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 186
Not applicableNot Yet RecruitingNCT07131280
What this trial is testing

National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Single vs Repeated Cycle of Granulocyte Colony-Stimulating Factor (GCSF) & Darbepoetin in Early Decompensated Cirrhosis

Who this might be right for
Decompensated Cirrhosis
Institute of Liver and Biliary Sciences, India 110
Large-scale testing (Phase 3)Study completedNCT00820976
What this trial is testing

Induction With or Without Granulocyte Colony-Stimulating Factor in AML Transplantation in AML

Who this might be right for
AML
Turkish Leukemia Study Group 260
Next Page